Skip to content
Clinical Trials – home
Research site

Specjalistyczna Praktyka Lekarska Slawomir Mandziuk

Poland ul. Chodzki 17/2, 20-093 Lublin, Poland

  • Non-small cell lung cancer · Non-small cell lung cancer metastatic · Small cell lung cancer
  • Adult patients

About Specializations

Specjalistyczna Praktyka Lekarska Slawomir Mandziuk in Lublin, Poland specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer metastatic, Small cell lung cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, focusing on innovative treatments for advanced non-small cell lung cancer (NSCLC). The institution is dedicated to exploring targeted therapies that address specific genetic mutations, such as the KRAS G12C mutation, which is prevalent in certain NSCLC patients.

  • Targeted Cancer Therapies
  • Genetic Mutation Research
  • Advanced Lung Cancer Treatment

Through its cutting-edge research, the center is contributing to the development of personalized medicine approaches, aiming to improve outcomes for patients with challenging cancer profiles.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Chodzki 17/220-093 LublinPoland
Recruiting now
no trials
Conditions studied
3

More sites in LublinPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Summit Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Irinotecan
  • Sponsor:Pharma Mar S.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.